Search

Sessions feature three 30-minute presentations on nanoscience, one each with strong orientation in biology, chemistry, and physics/applied mathematics. Presentations will be focused on discussion of recent work, although speakers will be expected to place the work in a context understandable to a broad audience.

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.